Proteasome Inhibitors
- Name
- Proteasome Inhibitors
- Accession Number
- DBCAT003056
- Description
Compounds that inhibit the function or proteolytic action of the PROTEASOME.
- ATC Classification
- Drugs
Drug Drug Description Delanzomib Delanzomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, and Lymphoma, Non-Hodgkin. Bortezomib A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. Carfilzomib A proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma. Ixazomib A monoclonal antibody used with other medications to treat multiple myeloma in patients who have received one other therapy already. Bortezomib D-mannitol Not Annotated - Drugs & Drug Targets